Does DABIGATRAN ETEXILATE Cause Urinary retention? 68 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Urinary retention have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.2% of all adverse event reports for DABIGATRAN ETEXILATE.
68
Reports of Urinary retention with DABIGATRAN ETEXILATE
0.2%
of all DABIGATRAN ETEXILATE reports
5
Deaths
59
Hospitalizations
How Dangerous Is Urinary retention From DABIGATRAN ETEXILATE?
Of the 68 reports, 5 (7.4%) resulted in death, 59 (86.8%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Urinary retention Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB